Needle-free retina drug delivery device launched

A revolutionary, needle-free technology that has been designed to deliver retina therapies non-invasively, to the back of the eye, has been launched.

Related Content:

ArticlesRetina

Application for Genentech’s faricimab accepted by U.S. FDA for treatment of wet AMD and DMO

Drug Delivery Methods Explored for Retinal Disease

Expanding the definition of AMD